Azerbaijan

Russia and Ukraine had been key players in the pharma markets of Central Asian and surrounding countries before the launch of the Russian invasion into its neighbor on 24 February. Because of this, both countries are poised to give ground in this growing regional market.

The Medicines Patent Pool has announced that the first shipments of dolutegravir under a fresh agreement covering upper-middle-income countries have reached Azerbaijan and Belarus.

There is growing in interest in boosting the first dose of a COVID-19 vaccine by administering a different vaccine as the second dose.

The Medicines Patent Pool is giving interested parties until 18 December to submit license applications for the HIV treatment dolutegravir in four middle-income countries, following announcement of the agreement last month.

Stada will pay $660m for a basket of 20 brands from Takeda to expand its consumer health portfolio in Russia and a number of strategically important CIS markets.

Reporting double-digit growth in the first half of 2019, Krka says it has mined marketing opportunities in new eastern European markets by introducing its established treatments for cardiovascular diseases

The Azerbaijani ministry of taxes has said that AstraZeneca and Pfizer have registered offices in Baku, the country's capital. Oleg Ril became director of AstraZeneca's new office, while Fuad Mustafaev was appointed legal representative of Pfizer.